Article

Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV elimination

2024-10-21

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Eliminating hepatitis C virus (HCV) infections is a goal set by the World Health Organization. This has become possible with the introduction of highly effective and safe direct-acting antivirals (DAA) but limitations remain due to undiagnosed HCV infections and loss of patients from the cascade of care at various stages, including those lost to follow-up (LTFU)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7a0058dd-605c-5804-96a6-97a1db620521
DOI: 10.21203/rs.3.rs-5024653/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Loss to follow-up of patients after antiviral treatment as an additional barrier to HCV eliminationDOI 10.21203/rs.3.rs-5024653/v1Read

Loss to follow-up: A significant barrier in the treatment cascade with direct-acting therapies.Semantic proximity Read

Effect of sustained viral clearance on liver-related mortality among individuals living with hepatitis C by treatment era: a population-based retrospective cohort studySemantic proximity Read

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study.Semantic proximity Read

Hepatitis C virus elimination: So close, so far?Semantic proximity Read

Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy: A National Observational Cohort StudySemantic proximity Read

Real-World Safety, Effectiveness, and Patient-Reported Outcomes in Patients with Chronic Hepatitis C Virus Infection Treated with Glecaprevir/Pibrentasvir: Updated Data from the German Hepatitis C-Registry (DHC-R).Semantic proximity Read

Efficacy of Sofosbuvir-Velpatasvir-Ribavirin Regimen for Retreatment of Chronic Hepatitis C in Patients with Prior DAA Failure: A Retrospective Study from a National Treatment CenterSemantic proximity Read

HCV reinfection incidence among individuals treated for recent infection.Semantic proximity Read

Ongoing Gaps in the Hepatitis C Care Cascade during the Direct-Acting Antiviral Era in a Large Retrospective Cohort in Canada: A Population-Based StudySemantic proximity Read

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study.Semantic proximity Read

Hepatitis C Virus (HCV) diagnosis, epidemiology and access to treatment in a UK cohortSemantic proximity Read

Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.Semantic proximity Read